Associated Papers
Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy.
Baleeiro RB et al.
Frontiers in Immunology, 2022
Mutated RAS: Targeting the "Untargetable" with T Cells.
Chatani PD et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2020
Select a paper to view details